Exploiting zebrafish genetics to identify genes affecting addiction-related phenotypes.
利用斑马鱼遗传学来识别影响成瘾相关表型的基因。
基本信息
- 批准号:9751829
- 负责人:
- 金额:$ 42.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAlcoholsAllelesAnimal ModelBehaviorBehavioralBehavioral AssayBehavioral GeneticsBiological FactorsBiological ProcessBiologyBreedingCRISPR/Cas technologyCandidate Disease GeneCardiovascular DiseasesCause of DeathCell physiologyCellsCessation of lifeChronicDataDevelopmentDevelopmental GeneDiseaseDrug AddictionEpidemicEvolutionFamilyFishesFutureGene ExpressionGene Expression ProfilingGenerationsGenesGeneticGenetic ModelsGenetic RiskGenetic ScreeningGenetic VariationGenomeGenotypeGoalsHealth Care CostsHeritabilityHumanHuman GeneticsHuman GenomeImpulsivityIndividualKnock-outMalignant NeoplasmsMapsMediatingMental disordersMicroarray AnalysisModelingMutagenesisMutationNicotineNicotine DependenceOutcomeOutcome StudyPathway interactionsPhenotypePopulationPredispositionReaction TimeRegulator GenesResearchRewardsRiskSiblingsSmokingSubstance abuse problemSystemTestingTimeTobaccoTobacco DependenceVariantVertebratesWorkWorld Health OrganizationZebrafishaddictioncausal variantcostdensitydevelopmental geneticsdrug of abusedrug rewardexome sequencinggene functiongenome wide association studyimprovedindividualized medicineinsightmutantneural circuitneural patterningneuronal patterningnext generation sequencingnicotine exposurenovelpersonalized medicinepopulation basedpreferenceprogramsprotein functionresponsescreeningsmoking addictiontranscriptome sequencingtreatment strategy
项目摘要
Exploiting zebrafish genetics to identify genes affecting addiction-related phenotypes
The cost of substance abuse in the US alone is estimated at $166 billion annually in preventable health
care costs, with tobacco ($130 billion) and alcohol ($25 billion) abuse contributing to the overwhelming
majority of this expense. The World Health Organization declared tobacco-related disease a global
epidemic, predicted to cause an estimated 8 million annual deaths worldwide by 2030, if unabated.
There is a vital need for increased understanding of the genetic and cell biological factors influencing
vulnerability to addiction including smoking to help identify individuals at risk and to inform treatment
strategies. As approaches to identify genetic risk are difficult in humans, research on genetic risk can be
facilitated by the use of animal models. Zebrafish are an established developmental and behavioral
genetic model species that show conserved responses to common drugs of abuse as well as behaviors
that model core phenotypes predictive of vulnerability to addiction. We shall identify genes affecting core
phenotypes associated with addiction by screening lines of ethyl nitrosurea (ENU)-mutagenised
zebrafish for sensitivity to nicotine reward and impulsivity. We test the hypothesis that genes that show
persistent adaptive changes in expression following chronic nicotine exposure are also addiction
vulnerability genes.
Our specific aims are:
1) To isolate 25 heritable loci affecting a) nicotine reward and b) impulsivity.
i) We will use behavioral assays in adult ENU-mutagenized zebrafish to identify families
showing altered nicotine reward and impulse control. We have developed a scalable, fully
automated behavioral assay system for this purpose. We will use analysis of microarray
or RNAseq data to identify genes that show persistent changes in expression following
chronic nicotine exposure as candidates for genes affecting nicotine addiction
vulnerability. We will pre-load the screen with families carrying mutations in these
candidate genes.
ii) We shall use exome sequencing to map the mutations in at least 10 families. The use of
ENU- mutagenized lines facilitates identification of the causal mutations (by generation of
strong phenotypes and/or by the ENU mutations acting as markers).
2) To identify the cell biological processes underlying the observed behavioral phenotypes.
i) We shall use additional (predicted functional) ENU mutations or targeted knockouts of the
identified genes to confirm genotype-phenotype associations.
ii) We shall perform RNA sequencing to gain insight into possible effects on gene
expression and cellular pathways affected.
iii) We shall perform developmental analyses to test the hypothesis that behavioral effects
are mediated by effects on neuronal patterning or neural circuit formation at
developmental timepoints.
The expected outcomes from this study are identification of novel genetic factors influencing core
behaviors predictive of vulnerability to drug addiction and increased understanding of the cellular
processes affected. These findings will enable future human genetic variation studies in these identified
genes, with the potential to develop more personalized therapies. Results from this work will have a
positive impact on individualized treatment efforts for tobacco dependence and addiction as a whole.
利用斑马鱼遗传学来识别影响成瘾相关表型的基因
仅在美国,就可以预防健康,仅在美国滥用药物的费用为1660亿美元
护理费用,烟草(1,300亿美元)和酒精(250亿美元)的滥用
这笔费用的大部分。世界卫生组织宣布与烟草有关的疾病全球
流行病预测,如果没有减弱,到2030年,全世界估计将导致大约800万例死亡。
至关重要的需要增加对影响遗传和细胞生物学因素的理解
成瘾的脆弱性,包括吸烟,以帮助识别有风险的人并告知治疗
策略。由于人类难以识别遗传风险的方法,因此对遗传风险的研究可能是
通过使用动物模型来促进。斑马鱼是既定的发展和行为
遗传模型物种显示出对常见滥用药物以及行为的保守反应
该模型核心表型可以预测成瘾的脆弱性。我们将确定影响核心的基因
通过筛选硝基尿素(ENU) - 淡核化的筛选线与成瘾相关的表型
斑马鱼对尼古丁奖励和冲动的敏感性。我们检验了显示的基因的假设
慢性尼古丁暴露后表达的持续自适应变化也是成瘾
脆弱性基因。
我们的具体目的是:
1)分离25个可遗传的基因座影响a)尼古丁奖励和b)冲动。
i)我们将在成人核糖核酸斑马鱼中使用行为分析来识别家庭
显示改变尼古丁的奖励和冲动控制。我们已经开发了一个可扩展的,充分的
为此目的,自动行为测定系统。我们将使用微阵列的分析
或RNASEQ数据以识别显示表达式持续变化以下的基因
慢性尼古丁暴露是影响尼古丁成瘾基因的候选者
脆弱性。我们将在其中携带突变的家庭预装屏幕
候选基因。
ii)我们将使用外显子组测序来绘制至少10个家庭的突变。使用
诱变线促进了因果突变的识别(通过产生
强烈的表型和/或通过充当标记的ENU突变)。
2)确定观察到的行为表型的基础的细胞生物学过程。
i)我们将使用其他(预测的功能性)ENU突变或针对性的敲除
确定的基因确认基因型 - 表型关联。
ii)我们将进行RNA测序以深入了解对基因的可能影响
表达和细胞途径受到影响。
iii)我们将进行发育分析以检验行为效应的假设
通过对神经元模式或神经回路形成的影响介导的
发展时间点。
这项研究的预期结果是对影响核心的新遗传因素的鉴定
可预测吸毒成瘾的脆弱性和对细胞的理解增加的行为
流程受影响。这些发现将使未来的人类遗传变异研究在这些发现
基因,有可能开发更多个性化疗法。这项工作的结果将有一个
对整个烟草依赖性和成瘾的个性化治疗工作的积极影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline Helen Brennan其他文献
Caroline Helen Brennan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline Helen Brennan', 18)}}的其他基金
Exploiting zebrafish genetics to identify genes affecting addiction-related phenotypes.
利用斑马鱼遗传学来识别影响成瘾相关表型的基因。
- 批准号:
10460608 - 财政年份:2018
- 资助金额:
$ 42.82万 - 项目类别:
Exploiting zebrafish genetics to identify genes affecting addiction-related phenotypes.
利用斑马鱼遗传学来识别影响成瘾相关表型的基因。
- 批准号:
10183210 - 财政年份:2018
- 资助金额:
$ 42.82万 - 项目类别:
相似国自然基金
GLS2调控的谷氨酰胺代谢影响儿童非酒精性脂肪肝发病风险的出生队列及机制研究
- 批准号:82373588
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
- 批准号:32360174
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
GLS2调控的谷氨酰胺代谢影响儿童非酒精性脂肪肝发病风险的出生队列及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
SENP6通过调控线粒体功能影响非酒精性脂肪肝的分子机制研究
- 批准号:82370576
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
非酒精性脂肪性肝病对心肌梗死后修复和重构的影响:肝脏外泌体来源miRNA的关键作用
- 批准号:82270342
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:
10679252 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Nucleus reuniens, chronic ethanol and cognitive deficits
核团聚、慢性乙醇和认知缺陷
- 批准号:
10825768 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
A longitudinal investigation of intersectional discrimination, alcohol use outcomes, and underlying mechanisms among bisexual people of color
对有色人种双性恋者的交叉歧视、饮酒结果和潜在机制的纵向调查
- 批准号:
10823696 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
Leveraging genetic and electronic health records data to identify novel targets and drugs for treating alcohol
利用遗传和电子健康记录数据来确定治疗酒精的新靶点和药物
- 批准号:
10888495 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别:
The role of remission in the intergenerational transmission of alcohol use disorder: Course, context, and offspring outcomes
缓解在酒精使用障碍代际传播中的作用:病程、背景和后代结果
- 批准号:
10736096 - 财政年份:2023
- 资助金额:
$ 42.82万 - 项目类别: